Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.97
+0.15 (0.44%)
At close: Feb 11, 2026, 4:00 PM EST
32.93
-0.04 (-0.11%)
After-hours: Feb 11, 2026, 4:10 PM EST
Immunocore Holdings Stock Forecast
Stock Price Forecast
The 10 analysts that cover Immunocore Holdings stock have a consensus rating of "Buy" and an average price target of $64.3, which forecasts a 95.06% increase in the stock price over the next year. The lowest target is $33 and the highest is $100.
Price Target: $64.3 (+95.06%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Immunocore Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +203.35% | Feb 4, 2026 |
| UBS | UBS | Strong Sell → Strong Buy Initiates $24 → $55 | Strong Sell → Strong Buy | Initiates | $24 → $55 | +66.84% | Jan 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $34 → $36 | Hold | Maintains | $34 → $36 | +9.21% | Nov 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $60 | Buy | Initiates | $60 | +82.01% | Oct 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +203.35% | Oct 22, 2025 |
Financial Forecast
Revenue This Year
410.99M
from 310.20M
Increased by 32.49%
Revenue Next Year
456.40M
from 410.99M
Increased by 11.05%
EPS This Year
-0.34
from -1.02
EPS Next Year
-1.05
from -0.34
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 428.9M | 513.5M | ||||
| Avg | 411.0M | 456.4M | ||||
| Low | 390.3M | 409.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 38.3% | 24.9% | ||||
| Avg | 32.5% | 11.0% | ||||
| Low | 25.8% | -0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.12 | 0.47 | ||||
| Avg | -0.34 | -1.05 | ||||
| Low | -0.86 | -2.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.